The burden of nonrheumatic valvular heart diseases in Iran between 1990 and 2017: Results from the global burden of disease study 2017.
The burden of nonrheumatic valvular heart diseases in Iran between 1990 and 2017: Results from the global burden of disease study 2017.
复制标题
DOI：
10.1016/j.ijcha.2022.100956
复制
发表时间：
2022-04
期刊：
影响因子：
--
通讯作者：
Azari S
中科院分区：
文献类型：
--
作者：
Arabloo J;Omidi N;Rezapour A;Sarabi Asiabar A;Mojtaba Ghorashi S;Azari S
非风湿性心脏瓣膜病是常见的心血管疾病之一。这项研究的目的是描述1990年至2017年伊朗的NRVD负担，并将研究结果与世界各地的结果进行比较，特别是北非和中东地区。使用伊朗和NAME地区2017年全球疾病负担研究（GBD 2017研究）的公开估计值，我们报告了1990年至2017年期间按年龄组和性别划分的寿命损失年（YLL），残疾生活年（YLD），残疾调整寿命年（DLDs）以及NRVD的患病率。2017年，伊朗估计有174，071例NRVD病例和957例死亡。此外，2017年伊朗的NRVD造成了1844起YLD，21，661起YLL和23，506起DALV。在1990年至2017年期间，伊恩的年龄标准化患病率增加了15%，死亡率增加了15.3%，而丹麦则增加了2%。尽管如此，在世界和NAME地区，年龄标准化的残疾和死亡率下降，年龄标准化的患病率上升，直到2017年。在伊朗，NRVD的负担正在上升。减少伊朗的NRVD负担需要制定适当的计划以满足患者的健康需求，减少可改变的风险因素，为疾病的早期诊断和管理分配充足的资源，并改善治疗技术的获取。
Nonrheumatic valvular heart diseases (NRVDs) are some of the common and treatable cardiovascular diseases. The objective of this study was to describe the burden of NRVDs in Iran from 1990 to 2017 and to compare the findings with those from the world and in particular, the North Africa and Middle East (NAME) region. Using publicly available estimates from the Global Burden of Disease 2017 Study (the GBD 2017 Study) for Iran and the NAME region, we reported the years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs), and the prevalence for NRVDs by age group and sex between 1990 and 2017. There were an estimated 174,071 cases and 957 deaths from NRVDs in Iran in 2017. In addition, 1844 YLDs, 21,661 YLLs, and 23,506 DALYs were caused by NRVDs in Iran in 2017. Between 1990 and 2017, the age-standardized prevalence rate increased in Ian by 15%, the death rate by 15.3%, and DALYs by 2%. Nevertheless, in the world and the NAME region, the age-standardized rates for DALYs and deaths decreased and the age-standardized prevalence rate increased till 2017. The burden of NRVDs is on the rise in Iran. A reduction in the burden of NRVDs in Iran requires the development of appropriate plans to meet the health needs of patients, the decrease of the modifiable risk factors, the allocation of adequate resources for the early diagnosis and management of the diseases, and an improvement in access to treatment technologies.
登录
查看更多内容
DOI：
10.1016/s0735-1097(96)00563-3
发表时间：
1997-03-01
影响因子：
24
作者：
Stewart, BF;Siscovick, D;Otto, CM
通讯作者：
Otto, CM
影响因子：
15.8
作者：
Cheng, Xunjie;Yang, Yang;Hu, Guoqi
通讯作者：
Hu, Guoqi
DOI：
10.1016/s0140-6736(17)32152-9
发表时间：
2017-09-16
期刊：
Lancet (London, England)
影响因子：
--
作者：
GBD 2016 Causes of Death Collaborators
通讯作者：
GBD 2016 Causes of Death Collaborators
影响因子：
158.5
作者：
Goldstone, Andrew B.;Chiu, Peter;Woo, Y. Joseph
通讯作者：
Woo, Y. Joseph
钙化性主动脉瓣疾病流行病学的变化：204 个国家和地区发病率、患病率和死亡的 30 年趋势
DOI：
10.18632/aging.202942
发表时间：
2021-05-11
期刊：
Aging
影响因子：
--
作者：
Yi B;Zeng W;Lv L;Hua P
通讯作者：
Hua P